Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase-4 and New Delhi Metallo-β-Lactamase-1.

Literature DB >> 31802119

Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase-4 and New Delhi Metallo-β-Lactamase-1.

Mohamad Yasmin^1,2,3,4, Derrick E Fouts⁵, Michael R Jacobs⁶, Hanan Haydar⁷, Steven H Marshall³, Richard White⁵, Roshan D'Souza⁵, Thomas P Lodise⁸, Daniel D Rhoads⁶, Andrea M Hujer^2,3, Laura J Rojas^2,3, Claudia Hoyen⁷, Federico Perez^2,3,4, Amy Edwards^2,7, Robert A Bonomo^{2,3,4,9,10,11,12,13}.

Abstract

In an infection with an Enterobacter sp. isolate producing Klebsiella pneumoniae Carbapenemase-4 and New Delhi Metallo-β-Lactamase-1 in the United States, recognition of the molecular basis of carbapenem resistance allowed for successful treatment by combining ceftazidime-avibactam and aztreonam. Antimicrobial synergy testing and therapeutic drug monitoring assessed treatment adequacy.

Entities: Chemical Species

Keywords: KPC; NDM; aztreonam; carbapenemase; ceftazidime-avibactam

Year: 2020 PMID： 31802119 PMCID： PMC7428388 DOI： 10.1093/cid/ciz1155

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

12 in total

1. Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2010-06-25 Impact factor: 17.586

2. A minimalistic approach to identify substrate binding features in B1 Metallo-beta-lactamases.

Authors: Andrés A Poeylaut-Palena; Pablo E Tomatis; Andreas I Karsisiotis; Christian Damblon; Ernesto G Mata; Alejandro J Vila
Journal: Bioorg Med Chem Lett Date: 2007-07-05 Impact factor: 2.823

3. Avibactam and inhibitor-resistant SHV β-lactamases.

Authors: Marisa L Winkler; Krisztina M Papp-Wallace; Magdalena A Taracila; Robert A Bonomo
Journal: Antimicrob Agents Chemother Date: 2015-02-17 Impact factor: 5.191

4. Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens.

Authors: Eric Wenzler; Matthew F Deraedt; Amanda T Harrington; Larry H Danizger
Journal: Diagn Microbiol Infect Dis Date: 2017-05-18 Impact factor: 2.803

5. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors: H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal: Antimicrob Agents Chemother Date: 2001-04 Impact factor: 5.191

6. Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient.

Authors: Maria F Mojica; Christopher P Ouellette; Amy Leber; M Brian Becknell; Monica I Ardura; Federico Perez; Masako Shimamura; Robert A Bonomo; Samuel L Aitken; Samuel A Shelburne
Journal: Antimicrob Agents Chemother Date: 2016-08-22 Impact factor: 5.191

7. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

Authors: Steven Marshall; Andrea M Hujer; Laura J Rojas; Krisztina M Papp-Wallace; Romney M Humphries; Brad Spellberg; Kristine M Hujer; Emma K Marshall; Susan D Rudin; Federico Perez; Brigid M Wilson; Ronald B Wasserman; Linda Chikowski; David L Paterson; Alejandro J Vila; David van Duin; Barry N Kreiswirth; Henry F Chambers; Vance G Fowler; Michael R Jacobs; Mark E Pulse; William J Weiss; Robert A Bonomo
Journal: Antimicrob Agents Chemother Date: 2017-03-24 Impact factor: 5.191

8. The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection.

Authors: Alasdair MacGowan; Sharon Tomaselli; Alan Noel; Karen Bowker
Journal: J Antimicrob Chemother Date: 2017-03-01 Impact factor: 5.790

9. Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection.

Authors: Johanna Berkhout; Maria J Melchers; Anita C van Mil; Seyedmojtaba Seyedmousavi; Claudia M Lagarde; Virna J Schuck; Wright W Nichols; Johan W Mouton
Journal: Antimicrob Agents Chemother Date: 2015-11-02 Impact factor: 5.191

10. Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.

Authors: David van Duin; Judith J Lok; Michelle Earley; Eric Cober; Sandra S Richter; Federico Perez; Robert A Salata; Robert C Kalayjian; Richard R Watkins; Yohei Doi; Keith S Kaye; Vance G Fowler; David L Paterson; Robert A Bonomo; Scott Evans
Journal: Clin Infect Dis Date: 2018-01-06 Impact factor: 9.079

16 in total

Review 1. Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations: The "Price of Progress".

Authors: Krisztina M Papp-Wallace; Andrew R Mack; Magdalena A Taracila; Robert A Bonomo
Journal: Infect Dis Clin North Am Date: 2020-09-30 Impact factor: 5.982

2. Aztreonam Combination Therapy: An Answer to Metallo-β-Lactamase-Producing Gram-Negative Bacteria?

Authors: Ryan K Shields; Yohei Doi
Journal: Clin Infect Dis Date: 2020-08-14 Impact factor: 9.079

Review 3. New β-Lactam-β-Lactamase Inhibitor Combinations.

Authors: Dafna Yahav; Christian G Giske; Alise Grāmatniece; Henrietta Abodakpi; Vincent H Tam; Leonard Leibovici
Journal: Clin Microbiol Rev Date: 2020-11-11 Impact factor: 26.132

4. Successful treatment of Verona integron-encoded metallo-β-lactamase-producing Klebsiella pneumoniae infection using the combination of ceftazidime/avibactam and aztreonam.

Authors: Ana Pelaez Bejarano; Raquel Sánchez-Del Moral; Olalla Montero-Pérez; Francisco Javier Martínez-Marcos
Journal: Eur J Hosp Pharm Date: 2021-10-29

5. Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients.

Authors: Marco Falcone; Francesco Menichetti; Dario Cattaneo; Giusy Tiseo; Sara Baldelli; Valentina Galfo; Alessandro Leonildi; Enrico Tagliaferri; Antonello Di Paolo; Manjunath P Pai
Journal: J Antimicrob Chemother Date: 2021-03-12 Impact factor: 5.790

Review 6. Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.

Authors: Xing Tan; Hwan Seung Kim; Kimberly Baugh; Yanqin Huang; Neeraja Kadiyala; Marisol Wences; Nidhi Singh; Eric Wenzler; Zackery P Bulman
Journal: Infect Drug Resist Date: 2021-01-18 Impact factor: 4.003

7. Antigen testing and non-infectious shedding of SARS-COV-2.

Authors: Yehuda Raveh; Jacques Simkins; Ramona Nicolau-Raducu
Journal: Infection Date: 2021-02-10 Impact factor: 3.553

8. Stenotrophomonas maltophilia Susceptibility Testing Challenges and Strategies.

Authors: Daniel D Rhoads
Journal: J Clin Microbiol Date: 2021-08-18 Impact factor: 5.948

9. Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing Enterobacterales During a Regional Outbreak.

Authors: Marco Falcone; Giusy Tiseo; Alberto Antonelli; Cesira Giordano; Vincenzo Di Pilato; Pietro Bertolucci; Eva Maria Parisio; Alessandro Leonildi; Noemi Aiezza; Ilaria Baccani; Enrico Tagliaferri; Lorenzo Righi; Silvia Forni; Spartaco Sani; Maria Teresa Mechi; Filippo Pieralli; Simona Barnini; Gian Maria Rossolini; Francesco Menichetti
Journal: Open Forum Infect Dis Date: 2020-01-21 Impact factor: 3.835

Review 10. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.

Authors: Stamatis Karakonstantis; Evangelos I Kritsotakis; Achilleas Gikas
Journal: Infection Date: 2020-09-01 Impact factor: 3.553